Mistry, Hema
Naghdi, Seyran
Underwood, Martin
Duncan, Callum
Madan, Jason
Matharu, Manjit
Funding for this research was provided by:
National Institute for Health Research (NIHR) Health Technology Assessment programme (NIHR132803, NIHR132803, NIHR132803, NIHR132803, NIHR132803, NIHR132803)
Article History
Received: 8 September 2023
Accepted: 27 October 2023
First Online: 5 December 2023
Declarations
:
: Not applicable.
: Not applicable.
: HM, SN, JM have no competing interests to declare.MU is chief investigator or co-investigator on multiple previous and current research grants from the UK National Institute for Health and Care Research, and is a co-investigator on grants funded by the Australian NHMRC and Norwegian MRC. He is a director and shareholder of Clinvivo Ltd that provides electronic data collection for health services research. He is part of an academic partnership with Serco Ltd, funded by the European Social Fund, related to return to work initiatives. He is a co-investigator on two current and one completed NIHR funded studies that have, or have had, additional support from Stryker Ltd. CD is chair of Scottish Intercollegiate Guideline Network (SIGN) 155 and has provided advise on the use of BTA, CGRP MAbs and CGRP antagonists to the Scottish Medicines Consortium and on Eptinezumab to NICE. He is the Secretary for the British Association for the Study of Headache 2015-2022 and he is a Board member of Anglo Dutch Migraine Association. MM is the President of the medical advisory board of the CSF Leak Association. He has received consulting fees from AbbVie, TEVA, Lundbeck, Eli Lilly, Salvia, Pfizer. He has received payment for the development of educational presentations from AbbVie, Pfizer and Eli Lilly and support for attending a meeting from Pfizer. He has is on the advisory board for AbbVie, TEVA, Lunbeck, Eli Lilly, Salvia and Pfizer. He has the following patent issued WO2018051103A1: System and method for diagnosing and treating headaches. He has stock options with Tesla, Adobe, Nvidia, META and Microsoft. He has received grants from Abbott, Medtronic and Ehlers Danlos society.